Individualized trigger assessment?

Are the CHWs give individualized information regarding triggers for the patients? We are recommending SPT or Specific IgE blood testing in the development of pathways. Has anyone else incorporated such a measure?

Views expressed on do not necessarily reflect EPA or MCAN policy or guidance. Read full disclaimer »